Lunai Bioworks Statistics

Total Valuation

Lunai Bioworks has a market cap or net worth of $29.29 million. The enterprise value is $31.37 million.

Market Cap	29.29M
Enterprise Value	31.37M

Important Dates

The last earnings date was Friday, November 14, 2025, after market close.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Lunai Bioworks has 23.43 million shares outstanding. The number of shares has increased by 49.41% in one year.

Current Share Class	23.43M
Shares Outstanding	23.43M
Shares Change (YoY)	+49.41%
Shares Change (QoQ)	+27.87%
Owned by Insiders (%)	30.43%
Owned by Institutions (%)	4.96%
Float	13.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.04

Current Ratio	0.04
Quick Ratio	0.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-25.58

Financial Efficiency

Return on equity (ROE) is -308.01% and return on invested capital (ROIC) is -20.86%.

Return on Equity (ROE)	-308.01%
Return on Assets (ROA)	-14.85%
Return on Invested Capital (ROIC)	-20.86%
Return on Capital Employed (ROCE)	119.88%
Revenue Per Employee	n/a
Profits Per Employee	-$4.52M
Employee Count	29
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -89.76% in the last 52 weeks. The beta is 0.36, so Lunai Bioworks's price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-89.76%
50-Day Moving Average	1.15
200-Day Moving Average	3.20
Relative Strength Index (RSI)	53.37
Average Volume (20 Days)	3,088,316

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-15.30M
Pretax Income	-130.98M
Net Income	-130.98M
EBITDA	-15.16M
EBIT	-15.30M
Earnings Per Share (EPS)	-$7.22

Full Income Statement

Balance Sheet

The company has $624,808 in cash and $2.71 million in debt, giving a net cash position of -$2.08 million or -$0.09 per share.

Cash & Cash Equivalents	624,808
Total Debt	2.71M
Net Cash	-2.08M
Net Cash Per Share	-$0.09
Equity (Book Value)	-13.04M
Book Value Per Share	-0.56
Working Capital	-18.92M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7.21M
Capital Expenditures	n/a
Free Cash Flow	-7.21M
FCF Per Share	-$0.31

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Lunai Bioworks does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-49.41%
Shareholder Yield	-49.41%
Earnings Yield	-447.16%
FCF Yield	-24.61%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on September 30, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Sep 30, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1